MaxCyte signs platform license agreement with Adicet Bio
Source: SeekingAlpha
2025-08-04 08:57:55 ET
More on MaxCyte
- MaxCyte, Inc. (MXCT) Q1 2025 Earnings Call Transcript
- MaxCyte GAAP EPS of -$0.10 beats by $0.01, revenue of $10.4M beats by $1.35M
- Seeking Alpha’s Quant Rating on MaxCyte
- Historical earnings data for MaxCyte
- Financial information for MaxCyte
Read the full article on Seeking Alpha
For further details see:
MaxCyte signs platform license agreement with Adicet Bio
MaxCyte Inc.
NASDAQ: MXCT
MXCT Trading
-7.28% G/L:
$1.0199 Last:
198,764 Volume:
$1.09 Open:
MXCT Latest News
May 12, 2026 04:05:00 pm
MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 GuidanceMXCT Stock Data
$82,138,988
103,153,769
1.05%
195
N/A
Biotechnology & Life Sciences
Healthcare
US
Rockville
